Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
45,497
archived clinical trials in
Breast Cancer

Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic Florida
mi
from
Weston, FL
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Florida
mi
from
Weston, FL
Click here to add this to my saved trials
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
University Cancer and Blood Center LLC
mi
from
Athens, GA
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
University Cancer and Blood Center LLC
mi
from
Athens, GA
Click here to add this to my saved trials
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Augusta University
mi
from
Augusta, GA
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Augusta University
mi
from
Augusta, GA
Click here to add this to my saved trials
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Illinois Cancer Specialists
mi
from
Arlington Heights, IL
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Illinois Cancer Specialists
mi
from
Arlington Heights, IL
Click here to add this to my saved trials
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
University of Illinois Cancer Center
mi
from
Chicago, IL
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
University of Illinois Cancer Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Indiana University Health Goshen Center For Cancer Care
mi
from
Goshen, IN
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Indiana University Health Goshen Center For Cancer Care
mi
from
Goshen, IN
Click here to add this to my saved trials
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Eastchester Center for Cancer Care
mi
from
Bronx, NY
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Eastchester Center for Cancer Care
mi
from
Bronx, NY
Click here to add this to my saved trials
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Wake Forest Baptist Hospital
mi
from
Winston-Salem, NC
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Wake Forest Baptist Hospital
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Fairview Hospital
mi
from
Cleveland, OH
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Fairview Hospital
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic Taussig Cancer Center
mi
from
Cleveland, OH
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Taussig Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Taussig Cancer Institute
mi
from
Mayfield Heights, OH
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Taussig Cancer Institute
mi
from
Mayfield Heights, OH
Click here to add this to my saved trials
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Bryn Mawr Hospital
mi
from
Bryn Mawr, PA
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Bryn Mawr Hospital
mi
from
Bryn Mawr, PA
Click here to add this to my saved trials
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
The Pennsylvania State University and Milton s. Hershey Medical Center
mi
from
Hershey, PA
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
The Pennsylvania State University and Milton s. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Paoli Hospital
mi
from
Paoli, PA
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Paoli Hospital
mi
from
Paoli, PA
Click here to add this to my saved trials
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
University of Tennessee Medical Center
mi
from
Knoxville, TN
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
University of Tennessee Medical Center
mi
from
Knoxville, TN
Click here to add this to my saved trials
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
M.D. Anderson Cancer Center
mi
from
Houston, TX
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
University of Virginia
mi
from
Charlottesville, VA
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Lynchburg Hematology Oncology
mi
from
Lynchburg, VA
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Lynchburg Hematology Oncology
mi
from
Lynchburg, VA
Click here to add this to my saved trials
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Peninsula Cancer Center
mi
from
Newport News, VA
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Peninsula Cancer Center
mi
from
Newport News, VA
Click here to add this to my saved trials
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Virginia Commonwealth University
mi
from
Richmond, VA
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Wheaton Franciscan Healthcare - Reiman Cancer Center
mi
from
Franklin, WI
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Wheaton Franciscan Healthcare - Reiman Cancer Center
mi
from
Franklin, WI
Click here to add this to my saved trials
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Aurora Baycare
mi
from
Green Bay, WI
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Aurora Baycare
mi
from
Green Bay, WI
Click here to add this to my saved trials
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Lankenau Medical Center
mi
from
Wynnewood, PA
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Lankenau Medical Center
mi
from
Wynnewood, PA
Click here to add this to my saved trials
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Research SiteR
mi
from
Brzozow,
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Research SiteR
mi
from
Brzozow,
Click here to add this to my saved trials
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Univ of North Carolina
mi
from
Chapel Hill, NC
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Stereotactic Body Radiation and Monoclonal Antibody to OX40 (MEDI6469) in Breast Cancer Patients With Metastatic Lesions
Phase I/II Study of Stereotactic Body Radiation Therapy to Metastatic Lesions in the Liver or Lung in Combination With Monoclonal Antibody to OX40 (MEDI6469) in Patients With Progressive Metastatic Breast Cancer After Systemic Therapy.
Status: Enrolling
Updated:  12/31/1969
Portland Providence Medical Center
mi
from
Portland, OR
Stereotactic Body Radiation and Monoclonal Antibody to OX40 (MEDI6469) in Breast Cancer Patients With Metastatic Lesions
Phase I/II Study of Stereotactic Body Radiation Therapy to Metastatic Lesions in the Liver or Lung in Combination With Monoclonal Antibody to OX40 (MEDI6469) in Patients With Progressive Metastatic Breast Cancer After Systemic Therapy.
Status: Enrolling
Updated: 12/31/1969
Portland Providence Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer
A Randomized, Placebo-Controlled Phase II Clinical Trial of Omega-3 PUFA Dietary Supplementation in Patients With Stage I-III Breast Carcinoma
Status: Enrolling
Updated:  12/31/1969
Comprehensive Cancer Center of Wake Forest University
mi
from
Winston-Salem, NC
Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer
A Randomized, Placebo-Controlled Phase II Clinical Trial of Omega-3 PUFA Dietary Supplementation in Patients With Stage I-III Breast Carcinoma
Status: Enrolling
Updated: 12/31/1969
Comprehensive Cancer Center of Wake Forest University
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
BYL719 Plus Letrozole or Exemestane for Patients With Hormone-Receptor Positive Locally-Advanced Unresectable or Metastatic Breast Cancer
A Phase I Trial of BYL719 Plus Letrozole or Exemestane for Patients With Hormone-Receptor Positive Locally-Advanced Unresectable or Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
BYL719 Plus Letrozole or Exemestane for Patients With Hormone-Receptor Positive Locally-Advanced Unresectable or Metastatic Breast Cancer
A Phase I Trial of BYL719 Plus Letrozole or Exemestane for Patients With Hormone-Receptor Positive Locally-Advanced Unresectable or Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
A Phase Ib/II, Multicenter Study of the Combination of LEE011 and BYL719 With Letrozole in Adult Patients With Advanced ER+ Breast Cancer
Status: Enrolling
Updated:  12/31/1969
University of California at San Diego, Moores Cancer Ctr Dept. of Moores Cancer Center
mi
from
San Diego, CA
Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
A Phase Ib/II, Multicenter Study of the Combination of LEE011 and BYL719 With Letrozole in Adult Patients With Advanced ER+ Breast Cancer
Status: Enrolling
Updated: 12/31/1969
University of California at San Diego, Moores Cancer Ctr Dept. of Moores Cancer Center
mi
from
San Diego, CA
Click here to add this to my saved trials
Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
A Phase Ib/II, Multicenter Study of the Combination of LEE011 and BYL719 With Letrozole in Adult Patients With Advanced ER+ Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital SC-5
mi
from
Boston, MA
Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
A Phase Ib/II, Multicenter Study of the Combination of LEE011 and BYL719 With Letrozole in Adult Patients With Advanced ER+ Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital SC-5
mi
from
Boston, MA
Click here to add this to my saved trials
Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
A Phase Ib/II, Multicenter Study of the Combination of LEE011 and BYL719 With Letrozole in Adult Patients With Advanced ER+ Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Sarah Cannon Research Institute SCRI SC
mi
from
Nashville, TN
Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
A Phase Ib/II, Multicenter Study of the Combination of LEE011 and BYL719 With Letrozole in Adult Patients With Advanced ER+ Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Sarah Cannon Research Institute SCRI SC
mi
from
Nashville, TN
Click here to add this to my saved trials
Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
A Phase Ib/II, Multicenter Study of the Combination of LEE011 and BYL719 With Letrozole in Adult Patients With Advanced ER+ Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University Medical Center Vanderbilt - Thompson Ln
mi
from
Nashville, TN
Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
A Phase Ib/II, Multicenter Study of the Combination of LEE011 and BYL719 With Letrozole in Adult Patients With Advanced ER+ Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University Medical Center Vanderbilt - Thompson Ln
mi
from
Nashville, TN
Click here to add this to my saved trials
Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
A Phase Ib/II, Multicenter Study of the Combination of LEE011 and BYL719 With Letrozole in Adult Patients With Advanced ER+ Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Texas Oncology, P.A. Texas Oncology - Sammons
mi
from
Dallas, TX
Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
A Phase Ib/II, Multicenter Study of the Combination of LEE011 and BYL719 With Letrozole in Adult Patients With Advanced ER+ Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Texas Oncology, P.A. Texas Oncology - Sammons
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
A Phase Ib/II, Multicenter Study of the Combination of LEE011 and BYL719 With Letrozole in Adult Patients With Advanced ER+ Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Cancer Therapy & Research Center / UT Health Science Center Dept of Onc
mi
from
San Antonio, TX
Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
A Phase Ib/II, Multicenter Study of the Combination of LEE011 and BYL719 With Letrozole in Adult Patients With Advanced ER+ Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Cancer Therapy & Research Center / UT Health Science Center Dept of Onc
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
A Phase Ib/II, Multicenter Study of the Combination of LEE011 and BYL719 With Letrozole in Adult Patients With Advanced ER+ Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Westmead,
Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
A Phase Ib/II, Multicenter Study of the Combination of LEE011 and BYL719 With Letrozole in Adult Patients With Advanced ER+ Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Westmead,
Click here to add this to my saved trials
Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
A Phase Ib/II, Multicenter Study of the Combination of LEE011 and BYL719 With Letrozole in Adult Patients With Advanced ER+ Breast Cancer
Status: Enrolling
Updated:  12/31/1969
H. Lee Moffitt Cancer Center & Research Institute H. Lee Moffitt Cancer Center
mi
from
Tampa, FL
Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
A Phase Ib/II, Multicenter Study of the Combination of LEE011 and BYL719 With Letrozole in Adult Patients With Advanced ER+ Breast Cancer
Status: Enrolling
Updated: 12/31/1969
H. Lee Moffitt Cancer Center & Research Institute H. Lee Moffitt Cancer Center
mi
from
Tampa, FL
Click here to add this to my saved trials
Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
A Phase Ib/II, Multicenter Study of the Combination of LEE011 and BYL719 With Letrozole in Adult Patients With Advanced ER+ Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Northwest Medical Specialties Northwest Medical Specialties
mi
from
Tacoma, WA
Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
A Phase Ib/II, Multicenter Study of the Combination of LEE011 and BYL719 With Letrozole in Adult Patients With Advanced ER+ Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Northwest Medical Specialties Northwest Medical Specialties
mi
from
Tacoma, WA
Click here to add this to my saved trials
Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
A Phase Ib/II, Multicenter Study of the Combination of LEE011 and BYL719 With Letrozole in Adult Patients With Advanced ER+ Breast Cancer
Status: Enrolling
Updated:  12/31/1969
UCSF Medical Center
mi
from
San Francisco, CA
Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
A Phase Ib/II, Multicenter Study of the Combination of LEE011 and BYL719 With Letrozole in Adult Patients With Advanced ER+ Breast Cancer
Status: Enrolling
Updated: 12/31/1969
UCSF Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib
Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib
Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib
Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib
Status: Enrolling
Updated:  12/31/1969
IU Simon Cancer Center
mi
from
Indianapolis, IN
Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib
Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib
Status: Enrolling
Updated: 12/31/1969
IU Simon Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib
Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib
Status: Enrolling
Updated:  12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib
Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib
Status: Enrolling
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib
Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib
Status: Enrolling
Updated:  12/31/1969
Lineberger Comprehensive Cancer Center, UNC
mi
from
Chapel Hill, NC
Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib
Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib
Status: Enrolling
Updated: 12/31/1969
Lineberger Comprehensive Cancer Center, UNC
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib
Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib
Status: Enrolling
Updated:  12/31/1969
MD Anderson
mi
from
Houston, TX
Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib
Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib
Status: Enrolling
Updated: 12/31/1969
MD Anderson
mi
from
Houston, TX
Click here to add this to my saved trials
Pilot Study of Anti-oxidant Supplementation With N-Acetyl Cysteine in Stage 0/I Breast Cancer
Pilot Study of Anti-oxidant Supplementation With N-Acetyl Cysteine in Stage 0/I Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Jefferson-Myrna Brind Center of Integrative Medicine
mi
from
Philadelphia, PA
Pilot Study of Anti-oxidant Supplementation With N-Acetyl Cysteine in Stage 0/I Breast Cancer
Pilot Study of Anti-oxidant Supplementation With N-Acetyl Cysteine in Stage 0/I Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Jefferson-Myrna Brind Center of Integrative Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials
PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk
PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk Using a Web-based Breast Cancer Screening Decision Aid Tool
Status: Enrolling
Updated:  12/31/1969
Edward S. Cooper Internal Medicine
mi
from
Philadelphia, PA
PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk
PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk Using a Web-based Breast Cancer Screening Decision Aid Tool
Status: Enrolling
Updated: 12/31/1969
Edward S. Cooper Internal Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials
PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk
PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk Using a Web-based Breast Cancer Screening Decision Aid Tool
Status: Enrolling
Updated:  12/31/1969
Family Medicine St. Leonard's Court
mi
from
Philadelphia, PA
PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk
PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk Using a Web-based Breast Cancer Screening Decision Aid Tool
Status: Enrolling
Updated: 12/31/1969
Family Medicine St. Leonard's Court
mi
from
Philadelphia, PA
Click here to add this to my saved trials
PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk
PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk Using a Web-based Breast Cancer Screening Decision Aid Tool
Status: Enrolling
Updated:  12/31/1969
Family Medicine
mi
from
Philadelphia, PA
PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk
PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk Using a Web-based Breast Cancer Screening Decision Aid Tool
Status: Enrolling
Updated: 12/31/1969
Family Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials
PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk
PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk Using a Web-based Breast Cancer Screening Decision Aid Tool
Status: Enrolling
Updated:  12/31/1969
Helen O. Dickens Center for Women's Health
mi
from
Philadelphia, PA
PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk
PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk Using a Web-based Breast Cancer Screening Decision Aid Tool
Status: Enrolling
Updated: 12/31/1969
Helen O. Dickens Center for Women's Health
mi
from
Philadelphia, PA
Click here to add this to my saved trials
PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk
PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk Using a Web-based Breast Cancer Screening Decision Aid Tool
Status: Enrolling
Updated:  12/31/1969
Penn Center for Primary Care
mi
from
Philadelphia, PA
PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk
PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk Using a Web-based Breast Cancer Screening Decision Aid Tool
Status: Enrolling
Updated: 12/31/1969
Penn Center for Primary Care
mi
from
Philadelphia, PA
Click here to add this to my saved trials